Yafit Stark

Dr. Stark is Vice President of Global Clinical Development at Teva Pharmaceutical Industries, Ltd. Dr. Stark is a pioneer and Expert in Global Clinical Development Strategy. Dr. Stark joined Teva in 1987. From 1991 to 1994 she was based in the US, where she established the Innovative R&D Division of Teva USA and was responsible for the clinical development of Copaxone®. Upon her return back to Israel, she continued building up the Global Clinical Infrastructures of Teva and was responsible also for the Clinical Development of other Teva products. . During her long-term career in the industry, Dr. Stark was involved in building up new clinical therapeutic areas such as Oncology and Biosmilars as well as advancing new technologies into clinical trials. Dr. Stark holds a Ph.D. degree in Pathology from the Sackler School of Medicine, Tel Aviv University, and a Post-Doctorate in Immuno-Histopathology from Tel Aviv University and the Weizmann Institute of Science.